Home -> Law Blog Directory -> Litigation Blogs -> How Appealing

Litigation

: How Appealing

"Supreme Court considers the reach of drug warning labels; The justices sound closely split as they hear arguments on whether product liability lawsuits should be allowed if a federal agency such as the FDA regulates the product"

"Supreme Court considers the reach of drug warning labels; The justices sound closely split as they hear arguments on whether product liability lawsuits should be allowed if a federal agency such as the FDA regulates the product": David G. Savage of The Los Angeles Times provides this news update.

Jerry Markon of The Washington Post has a news update headlined "Supreme Court Hears Pharmaceutical Case."

Mark Sherman of The Associated Press reports that "Court weighs amputee's case; limits on drug suits."

Reuters reports that "Top court weighs drugmaker liability for harm."

And earlier today, Warren Richey of The Christian Science Monitor previewed the oral argument in an article headlined "Supreme Court takes up drug warning labels; The case pits a Vermont musician who lost a limb against a pharmaceutical giant."

You can access today's oral argument transcript in Wyeth v. Levine, No. 06-1249, by clicking here.

Full post as published by How Appealing on November 03, 2008 (boomark / email).